Cargando…
An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system
Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Schwann cells (SCs). Macrophages are abundant in neurofibromas, and macrophage targeted interventions may have therapeutic potential in these tumors. We generated gene expression data from fluorescence-activated cell sorted (FACS...
Autores principales: | Choi, Kwangmin, Komurov, Kakajan, Fletcher, Jonathan S., Jousma, Edwin, Cancelas, Jose A., Wu, Jianqiang, Ratner, Nancy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335359/ https://www.ncbi.nlm.nih.gov/pubmed/28256556 http://dx.doi.org/10.1038/srep43315 |
Ejemplares similares
-
STAT3 inhibition reduces macrophage number and tumor growth in neurofibroma
por: Fletcher, Jonathan S., et al.
Publicado: (2018) -
Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment
por: Kershner, Leah J., et al.
Publicado: (2022) -
After Nf1 loss in Schwann cells, inflammation drives neurofibroma formation
por: Fletcher, Jonathan S, et al.
Publicado: (2019) -
Angiogenic and invasive properties of neurofibroma Schwann cells
Publicado: (1990) -
The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin
por: Rice, Frank L., et al.
Publicado: (2019)